相关实验视频
Updated: May 28, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
基于社区的HbA1c测试计划,用于在社区药房早期检测未诊断的糖尿病
Aiko Shono1, Aki Morihiro2, Nobue Harada2
1Laboratory of Public Health, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
The International journal of pharmacy practice
|February 12, 2025
概括
日本的社区药房提供随行血红蛋白A1c (HbA1c) 测试,以检测未诊断的糖尿病 (DM). 该计划成功识别了有风险的个人,特别是那些错过常规检查的人,突出了社区药房健康查的价值.
科学领域:
- 公共卫生 公共卫生
- 社区药房实践 社区药房实践
- 糖尿病 查 糖尿病 查
背景情况:
- 自2014年以来,在日本社区药房提供了用于HbA1c测试的指尖血液采样.
- 2016年,由广岛县的米哈拉药房协会开发了一个利用HbA1c测试的社区计划.
研究的目的:
- 评估社区计划是否可以检测未诊断的糖尿病 (DM).
- 为了比较访问程序的参与者与未访问程序的参与者之间的结果.
主要方法:
- 该计划涉及药剂师咨询后HbA1c测试和填写问卷,以获得生活方式,人口统计和健康数据.
- 从2016-2018财政年度的数据,从参与者问卷进行了追溯分析.
主要成果:
- 在1933年唯一的参与者 (年龄在40-74岁之间) 中,73.7%有资格参加国家健康检查计划.
- 大约40%的参与者错过了例行检查;23.8%的HbA1c水平≥5.6%,2.7%的HbA1c水平≥6.5%.
结论:
- 随行HbA1c测试计划有效地确定了患DM风险的居民,特别是那些不定期参加检查的人.
- 广泛采用可能会增加未被诊断的糖尿病的早期检测,并利用社区药房资源.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149

